Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

112.19USD
29 Jul 2016
Change (% chg)

$0.93 (+0.84%)
Prev Close
$111.26
Open
$110.66
Day's High
$112.43
Day's Low
$110.50
Volume
5,486,248
Avg. Vol
4,512,176
52-wk High
$136.40
52-wk Low
$92.98

Friedman, Michael 

Dr. Michael A. Friedman, M.D., serves as Independent Director of Celgene Corp. He is a member of the Nominating Committee since April 2011. Dr. Friedman currently serves as Chief Executive Officer of City of Hope, cancer research, treatment and education institution, as well as Director of the organization’s Comprehensive Cancer Center and holder of the Irell & Manella Cancer Center Director’s Distinguished Chair. Before City of Hope, Dr. Friedman was Senior Vice President of Research and Development, Medical and Public Policy for Pharmacia Corporation and Chief Medical Officer for biomedical preparedness at PhRMA. Additionally, Dr. Friedman previously served as Deputy Commissioner for the U.S. Food and Drug Administration (FDA), later serving as Acting Commissioner, and as Associate Director of the National Cancer Institute, National Institutes of Health. Since 2004, Dr. Friedman serves on the Independent Citizens’ Oversight Committee which governs the California Institute for Regenerative Medicine and oversees the implementation of California’s stem cell research effort. Dr. Friedman is a member of the Board of Directors of MannKind Corporation and Smith & Nephew plc. He also serves on the Board of Trustees for Tulane University and the California State Stem Cell Initiative.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

22,472,900

Jacqualyn Fouse

8,073,500

Mark Alles

7,912,170

Peter Kellogg

5,705,640

Thomas Daniel

7,341,980

Scott Smith

4,783,240
As Of  30 Dec 2015